Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11891393 Functionalized heterocycles as antiviral agents

Patent 11891393 was granted and assigned to Enanta Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

0

Current Assignee

Enanta Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Samuel Bartlett0

Joseph Panarese0

Dexter Davis0

Nathaniel Kenton0

Yat Sun Or0

Katherine Chong0

Date of Patent

February 6, 2024

0

Patent Application Number

175177400

Date Filed

November 3, 2021

0

Patent Citations

US Patent 7615569 Inhibitors of ion channels

0

US Patent 7232825 Phenylaminopyrimidine derivatives and methods of use

0

US Patent 7312214 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors

0

US Patent 7411003 Inhibition of Hepatitis B virus by cyclohexenone compounds from

0

US Patent 9938301 Dihydropyrimido fused ring derivative as HBV inhibitor

0

US Patent 10179131 Hepatitis B antiviral agents

0

US Patent 10179792 Hepatitis B antiviral agents

0

US Patent 10189846 Hepatitis B antiviral agents

0

...

Patent Primary Examiner

Charanjit Aulakh

0

CPC Code

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11891393 Functionalized heterocycles as antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool